From: Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Variable | All participants (n = 13) | Non-controllers (n = 10) | Controllers (n = 3) |
---|---|---|---|
Demographics | |||
 Sex (M/F), n | 12/1 | 9/1 | 3/0 |
 Risk group (MSM/HTS), n | 12/1 | 9/1 | 3/0 |
 Ethnic group (Caucasian/Latin), n | 12/1 | 9/1 | 3/0 |
 Age (years) | 42 (39–47) | 43 (39–47) | 34 (33–38) |
 BMI (kg/m2) | 22.9 (20.9–24) | 22.3 (21.1–23.4) | 24.3 (22.2–25) |
Treatment and clinical characteristics | |||
 ART regimen, n (TDF_FTC_RAL/ABC_3TC_RAL/ABC_3TC_DTG) | 2/9/2 | 2/6/2 | 0/3/0 |
 Viral reservoir (HIV-1 DNA cp/106 CD4+ T-cells) | 140 (65–361) | 165 (76.2–415.7) | 65 (62.5–116.5) |
 CD4+ T cell (cells/mm3) | 728 (648–1182) | 839 (581.8–1293.8) | 657 (652.5–814) |
 CD4+ T cell (%) | 42.9 (42.2–49.3) | 43.4 (42.3–48.1) | 42.2 (38.4–48.1) |
 CD4/CD8 T cell counts ratio | 1.4 (1.2–1.6) | 1.4 (1.2–1.5) | 1.3 (1.1–1.6) |